Catalyst Wire Dossier Catalyst Wire Dossier

Ropivacaine 0.5%

ropivacaine
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Ropivacaine 0.5%, covering 2015-03-17 to 2025-12-23. Get the full timeline:

Most recent: Clinical Trial Update: Comparative Analysis Of Dexmedetomidine And Dexamethasone As An Adjuvant To 0.5%Ropivacaine On Onset Of Ultrasound Guided Supraclavicular Brachial Plexus Block In Patients Undergoing Upper Limb Surgeries [Phase 2, Phase 3]

See pricing